Health
Bone density loss from Anastrozole partially reverses after treatment stops – Hindustan Times
A study by researchers from Queen Mary University of London shows that bone loss known to be associated with the use of the breast cancer prevention drug Anastrozole…
A study by researchers from Queen Mary University of London shows that bone loss known to be associated with the use of the breast cancer prevention drug Anastrozole partially reverses, particularly at the lumbar spine, after stopping treatment.
Anastrozole is a hormone treatment recommended by NICE to prevent breast cancer in high-risk postmenopausal women.
The results, published in the British Journal of Cancer, are from a sub-study of 1,410 women from the International Breast cancer Intervention…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News21 hours agoNew FLC President has regional lens – Proctor
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?